ZERO POINT FIVE THERAPEUTICS, INC.

Profile

Company Names

ZERO POINT FIVE THERAPEUTICS, INC.

Addresses

915 S. EATON STREET, BALTIMORE, MD 21224

Phone Numbers

301-327-0118

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$11,519,937.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2025-04-02 
$4,299,420.00 
$5,333,250.00 
$1,033,830.00 
Equity 
1
2023-06-27 
$7,220,517.00 
$10,140,859.00 
$2,920,342.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSEPH 
 
AMPREY III 
EXECUTIVE OFFICER, DIRECTOR
ZERO POINT FIVE THERAPEUTICS, INC.
BEN 
 
AUSPITZ 
DIRECTOR
LIGOCYTE PHARMACEUTICALS INC   |  ULTRAGENYX PHARMACEUTICAL INC.   |  SYMBIOMIX THERAPEUTICS, LLC   |  UNUM THERAPEUTICS, INC.   |  PRECISION BIOSCIENCES INC   |  COMPASS THERAPEUTICS LLC   |  CHECKMATE PHARMACEUTICALS, INC.   |  INDALO THERAPEUTICS, INC.   |  MEVES PHARMACEUTICALS, INC.   |  ZERO POINT FIVE THERAPEUTICS, INC.   |  ANTLIA BIOSCIENCE, INC.
JODI 
 
JAHIC 
DIRECTOR
SA IGNITE INC.   |  TALLYX, INC.   |  ZERO POINT FIVE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-04-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-02 
2023-07-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-27 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#